Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
Funding for research projects bringing basic knowledge to use at the patient level in terms of e.g. disease prognosis, treatment prediction or patient stratification. |
|
Característiques principals
The award is expected to accelerate important fields of translational research and to improve the speed of innovation implementation in diabetes care.. Translating knowledge from basic science to patient care is an area that is typically underfunded. This has led to a horrifying average of 17 years from the time an innovation is realised until it is deployed in clinical practice. Supporting Precision Diabetes Medicine is expected to shorten this lag time and improve the lives of people with diabetes. Precision Diabetes Medicine refers to attempts of tailoring diagnosis, prediction, prevention and treatment of diabetes to specific subgroups, and ultimately to the individual. This requires novel approaches and integration of multidimensional data. |
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
|
Convocatòria (URL)
http://www.europeandiabetesfoundation.org/workshops/116-efsdnovo-nordisk-foundation-precision-diabetes-medicine-award-programme.html |
|
Requisits
Applications for an EFSD/Novo Nordisk grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. Applications can be made by any paid-up member of EASD |
|
Dotació
Danish Krone (DKK) 1 awardee 2 million (~ €268,000) and 2 runners-up 500,000 DKK (~ €67,000) each to be paid to the awardee’s institution. |
Arxius
| Arxiu |
|---|
| EFSD_Novo Nordisk Foundation Precision Diabetes Medicine Award Programme _ EFSD.pdf |
| Application Form_ EFSD NNF Precision Diabetes Medicine Award 2022.doc |